NLRP3 inhibitors (Schrodinger)

N/A

Report date: 2025/06/11 10:53:31
NME

Base Information

Drug NameNLRP3 inhibitors (Schrodinger)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionNACHT, LRR and PYD domains-containing protein 3 inhibitors
TargetsNACHT, LRR and PYD domains-containing protein 3
Therapy Area/IndicationsInflammationAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSchrodinger Inc
China Registration ClassN/A

Develop Information

Active CompaniesSchrodinger Inc
Inactive CompaniesN/A
Active IndicationsInflammationAutoimmune Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A